is semaglutide covered by medicaid for weight loss Access GLP-1 medications through Medicare GLP-1 Bridge Medicare, Medicaid to experiment with

Grimes et al., 2019)

Last updated: 16th June 2026 References 1

To provide timely, complementary evidence, we conducted a comparison of tirzepatide and semaglutide in patients at low, moderate and high cardiovascular risk who were diagnosed with obesity and type 2 diabetes and subgroups with specific cardiovascular conditions

Tirzepatide may be more appropriate for patients with type 2 diabetes, insulin resistance, or those requiring stronger hormonal regulation for appetite and blood sugar control

11-13 GLP-1 receptors are expressed in multiple tissues, therefore, GLP-1RAs have multiple mechanisms of action (Figure 2)